ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Zota Healthcare Earnings Call: Key Takeaways

Zota reported robust FY26 performance with 83.86% revenue growth, achieving EBITDA turnaround and significant Davaindia store expansion to 2,579 outlets.

Why this was an Alfa AlertNot a filter event. Strong performance was delivered, but there is no explicit beat mentioned relative to a specific prior numerical guidance range.
Highlights
Revenue growth83.86% YoY growth for FY26.
MarginsGross margin expanded 714 bps to 60.28% in FY26.
Demand visibilityStrong on-ground visibility from 2,500+ store network.
Management confidenceHigh; confident in scaling to 5,000+ stores by FY29.

Growth

FY26 consol revenue stood at ₹53,865 lakhs (up 83.86% YoY); EBITDA at ₹2,597 lakhs vs negative in FY25.

Outlook

Targeting 5,000+ Davaindia stores by FY29; planned addition of 500-700 stores in FY27.

Risks

Expansion moderation in Q2/Q3 to focus on profitability; MSME compliance reducing payable days.

Source

Earnings Call filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.

Read the document ↗

Zota Healthcare Ltd: key numbers

Share price
₹1,327.30
Market cap
₹4,597 Cr
Revenue (annual)
₹538.7 Cr
Net profit (annual)
₹-73.94 Cr
P/E (TTM)
-40.8×Sector 43.8×
Promoter holding
49.38%+0.00% QoQ
FII holding
6.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zota Healthcare Ltd

All →